Integrative cluster classification to predict pathological complete response to neoadjuvant chemotherapy in early breast cancer

被引：2
|
作者：
Alba, Emilio
Rueda, Oscar M.
Lluch, Ana
Albanell, Joan
Chin, Suet-Feung
Chacon, Jose Ignacio
Calvo, Lourdes
De La Haba, Juan
Bermejo, Begona
Ribelles, Nuria
Cirauqui, Beatriz
Ramos Vazquez, Manuel
Arcusa Lanza, Maria Angeles
Maria Carrasco, Eva
Herranz, Jesus
Chiesa, Massimo
Caballero, Rosalia
Santonja Climent, Angela
Rojo, Federico
Caldas, Carlos
机构：
[1] Hosp Clin Univ Virgen de la Victoria, GEICAM Spanish Breast Canc Grp, Malaga, Spain
[2] Canc Res UK Cambridge Inst, Cambridge, England
[3] Hosp Clin Univ Valencia, GEICAM Spanish Breast Canc Grp, Ctr Invest Biomed Red Oncol, CIBERONC ISCIII, Valencia, Spain
[4] Hosp del Mar, GEICAM Spanish Breast Canc Grp, Barcelona, Spain
[5] Canc Res UK, Cambridge Res Inst, Cambridge, England
[6] Hosp Virgen de la Salud, GEICAM Spanish Breast Canc Grp, Toledo, Spain
[7] Complejo Hosp Univ A Coruna, GEICAM Spanish Breast Canc Grp, La Coruna, Spain
[8] Univ Cordoba, Biomed Res Inst Maimonides, Hosp Univ Reina Sofia, Cordoba, Spain
[9] Spanish Breast Canc Grp, Ctr Invest Biomed Red Oncol, CIBERONC ISCIII GEICAM, Cordoba, Spain
[10] Hosp Univ Reg & Virgen de la Victoria Malaga, IBIMA, Unidad Gest Clin Interctr Oncol, Malaga, Spain
[11] Hosp Badalona Germans Trias & Pujol, Med Oncol Dept, Catalan Inst Oncol, Badalona, Spain
[12] GEICAM Spanish Breast Canc Grp, Ctr Oncol Galicia, La Coruna, Spain
[13] Hosp Terrassa, GEICAM Spanish Breast Canc Grp, Barcelona, Spain
[14] GEICAM Spanish Breast Canc Grp, Madrid, Spain
[15] Hosp Clin Univ Virgen de la Victoria, Malaga, Spain
[16] Fdn Jimenez Diaz, Madrid, Spain
[17] CIBERONC ISCIII, Ctr Invest Biomed Red Oncol, Madrid, Spain
[18] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.579
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
579
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer
    Cortazar, Patricia
    Geyer, Charles E., Jr.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1441 - 1446
  • [42] Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy
    Asaoka, Mariko
    Narui, Kazutaka
    Suganuma, Nobuyasu
    Chishima, Takashi
    Yamada, Akimitsu
    Sugae, Sadatoshi
    Kawai, Saori
    Uenaka, Natsuki
    Teraoka, Saeko
    Miyahara, Kana
    Kawate, Takahiko
    Sato, Eichi
    Nagao, Toshitaka
    Matsubara, Yuka
    Gandhi, Shipra
    Takabe, Kazuaki
    Ishikawa, Takashi
    EJSO, 2019, 45 (12): : 2289 - 2294
  • [43] Prediction of pathological complete response to neoadjuvant chemotherapy in early triple negative breast cancer patients by serial breast ultrasound examination
    Rapoport, Bernardo
    Smit, Teresa
    Heyman, Liezl
    Moosa, Farhana
    Benn, Carol Ann
    CANCER RESEARCH, 2021, 81 (04)
  • [44] Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy
    Schott, AF
    Roubidoux, MA
    Helvie, MA
    Hayes, DF
    Kleer, CG
    Newman, LA
    Pierce, LJ
    Griffith, KA
    Murray, S
    Hunt, KA
    Paramagul, C
    Baker, LH
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (03) : 231 - 238
  • [45] Comprehensive Profiling of Cancer-Associated Cells in the Blood of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy to Predict Pathological Complete Response
    Pore, Adity A.
    Dhanasekara, Chathurika S.
    Navaid, Hunaiz Bin
    Vanapalli, Siva A.
    Rahman, Rakhshanda Layeequr
    BIOENGINEERING-BASEL, 2023, 10 (04):
  • [46] Early Optical Tomography Changes Predict Breast Cancer Response to Neoadjuvant Chemotherapy
    Lim, E. A.
    Gunther, J. E.
    Flexman, M.
    Kim, H. K.
    Hibshoosh, H.
    Kalinsky, K.
    Crew, K.
    Maurer, M.
    Taback, B.
    Feldman, S.
    Brown, M.
    Refice, S.
    Alvarez-Cid, M.
    Hielscher, A.
    Hershman, D. L.
    CANCER RESEARCH, 2012, 72
  • [47] MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer
    Sener, Stephen F.
    Sargent, Rachel E.
    Lee, Connie
    Manchandia, Tejas
    Le-Tran, Vivian
    Olimpiadi, Yuliya
    Zaremba, Nicole
    Alabd, Andrew
    Nelson, Maria
    Lang, Julie E.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (06) : 903 - 910
  • [48] Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy
    Anne F. Schott
    Marilyn A. Roubidoux
    Mark A. Helvie
    Daniel F. Hayes
    Celina G. Kleer
    Lisa A. Newman
    Lori J. Pierce
    Kent A. Griffith
    Susan Murray
    Karen A. Hunt
    Chintana Paramagul
    Laurence H. Baker
    Breast Cancer Research and Treatment, 2005, 92 : 231 - 238
  • [49] Can radiological response in the breast to neoadjuvant chemotherapy predict pathological response in the axilla?
    Rolph, Rachel
    Morgan, Catrin
    Loo, Yew
    Stringfellow, Thomas
    Balasubramian, Rajesh
    Kovacs, Tibor
    Kothari, Ashtosh
    Pinder, Sarah
    Hamed, Hisham
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 566 - 566
  • [50] Can radiological response in the breast to neoadjuvant chemotherapy predict pathological response in the axilla?
    Morgan, Catrin
    Loo, Yew
    Stringfellow, Thomas
    Balasubramian, Rajesh
    Hamed, Hisham
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 19 - 19
12345